The European Patent Office appeals board upheld the decision made by the EPO after its initial review in 2018.
In Nature this week: genomic analysis of rapeseed, universal target enrichment method for metagenomic sequencing, and more.
Jennifer Doudna and Emmanuelle Charpentier are being awarded Israel's Wolf Prize in medicine for their CRISPR work, the Associated Press reports.
Horizon also said it will provide access to the technology to business partners for the development of more effective multi-gene knockout cell therapy programs.
Daiichi Sankyo plans to use the ERS IP to support its own R&D initiatives to address areas of unmet medical need, the company said.
In December, the companies agreed to develop CRISPR tools with the aim of generating new engineered cell lines for the biopharmaceutical industry.
Dalhousie University's Françoise Baylis discusses He Jiankui and the ethics of heritable human genome editing research in a Boston Globe op-ed.
Researchers in academia and industry are showing interest in the scale offered by Inscripta's Onyx platform for genome editing, launched in October.
NEB plans to expand its product lines into new areas of research including genome editing, the companies said.
A Chinese court has sentenced He Jiankui and two others to three years in jail for editing the genomes of infants as embryos.
Following its departure from the European Union, the UK is to implement a fast-track visa program aimed at attracting scientific talent to Britain, according to BBC News.
ScienceInsider reports that researchers in Brazil are concerned that a creationist was chosen to run the agency that oversees graduate study programs there.
The Washington Post reports that researchers are quickly analyzing the coronavirus that has been causing illness and sharing their findings.
In PLOS this week: common variant associated with BMI in Arctic populations, analysis of microRNA markers associated with being born small for gestational age, and more.